In addition to my work as a researcher, I also serve on several national and international committees. This includes a position as member of the Norwegian Biotechnology Advisory Board.
The role of this board is to both encourage public discussion and debate and to provide advice to the Norwegian government on issues related to biotechnology, and particularly on social and ethical issues. The work of this advisory board covers both the use of biotechnology in medical applications and the use of genetically modified organisms in agriculture. The board is made up of a diverse range of professionals with very different perspectives, beliefs and areas of expert knowledge. Our discussions are always extremely interesting, informative and very often involve canvassing a range of issues and different positions on controversial topics of public interest. For example, since I was appointed as a member, we have come with advice on topics as diverse as whether single women should have State supported access to in vitro fertilisation (IVF), whether parents should be allowed to perform genetic testing on their children, whether sperm donors should be subject to genetic testing, how the regulation of genetic testing for medical research may differ from that for clinical applications and whether Norway should accept GM crop products for import. Our recommendations on the topics we discuss are always made publically available (in Norwegian) and when the Board is divided in its views, the positions of each Board member are made clear in the recommendation.
As part of its work and in addition to the meetings of its members, the Norwegian Biotechnology Advisory Board also regularly arranges public events, lectures and seminars. On June 8th, I was fortunate enough to be invited to give a breakfast seminar in Oslo on the topic of assessing social and ethical aspects of GMOs, which was videoed and is now available online. In this talk, I drew on the research we have been performing in The Agri/Cultures Project and sought to explain why assessing social and ethical issues around GMOs is important, as well as show different ways in which this can be approached and argue that we need to be considering these matters at various points along the innovation chain.
What was particularly interesting for me was to see how the announcement of this seminar was treated on social media. Before I even got a chance to give my talk, groups on Facebook and users of Twitter were already dismissing the content as biased and irrelevant, as well as criticising me and GenØk Centre for Biosafety for being anti-GMO activists. Although none of the net trolls seemed to have the courage to attend the event, actually hear my thoughts on the topic and have a face to face conversation with me, it is amazing how the GMO debate continues to generate such strong emotional reactions amongst people. Indeed, in my talk I try to highlight how this emotional response is indicative of the importance of addressing social and ethical dimensions of the technology. I also challenged this approach to the debate by suggesting that we need to move out of the current trench warfare approach of pro-anti GMO camps dug in and defending their positions by throwing bombs at the other, and actually start to have more sophisticated conversations in which we look at concrete cases, contexts and empirical research. This is becoming increasingly important as biotechnology is now diversifying rapidly through the use of genome editing techniques like CRISPR-Cas9 and we need to carefully consider what we mean by the term ‘GMO’ and whether all biotechnology techniques should be considered alike in terms of their potential social and environmental impacts, ethical aspects and regulation.